TTRX
NASDAQ · Pharmaceuticals
Turn Therapeutics Inc
$3.80
+0.11 (+2.97%)
Open$3.65
Previous Close$3.69
Day High$3.80
Day Low$3.65
52W High$26.50
52W Low$2.57
Volume—
Avg Volume16.9K
Market Cap113.05M
P/E Ratio—
EPS$-0.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 28.41M | 28.26M | 24.54M |
| Net Income | 5.07M | 4.33M | 4.07M |
| Profit Margin | 17.8% | 15.3% | 16.6% |
| EBITDA | 7.12M | 6.76M | 5.89M |
| Free Cash Flow | 5.68M | 5.26M | 4.99M |
| Rev Growth | +18.7% | -2.9% | -7.4% |
| Debt/Equity | 0.72 | 0.77 | 0.81 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |